These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 12126456)

  • 1. Distribution of cyclosporin in organ transplant recipients.
    Akhlaghi F; Trull AK
    Clin Pharmacokinet; 2002; 41(9):615-37. PubMed ID: 12126456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin pharmacokinetics in paediatric transplant recipients.
    Cooney GF; Habucky K; Hoppu K
    Clin Pharmacokinet; 1997 Jun; 32(6):481-95. PubMed ID: 9195117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients.
    Belitsky P; Dunn S; Johnston A; Levy G
    Clin Pharmacokinet; 2000 Aug; 39(2):117-25. PubMed ID: 10976658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
    Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
    J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral terbinafine treatment on cyclosporin pharmacokinetics in organ transplant recipients with dermatophyte nail infection.
    Jensen P; Lehne G; Fauchald P; Simonsen S
    Acta Derm Venereol; 1996 Jul; 76(4):280-1. PubMed ID: 8869684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of simvastatin on cyclosporine unbound fraction and apparent blood clearance in heart transplant recipients.
    Akhlaghi F; McLachlan AJ; Keogh AM; Brown KF
    Br J Clin Pharmacol; 1997 Dec; 44(6):537-42. PubMed ID: 9431828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.
    del Mar Fernández De Gatta M; Santos-Buelga D; Domínguez-Gil A; García MJ
    Clin Pharmacokinet; 2002; 41(2):115-35. PubMed ID: 11888332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of cyclosporine A in rat tissues and human kidney transplant biopsies--a method suitable for small (<1 mg) samples.
    Noll BD; Coller JK; Somogyi AA; Morris RG; Russ GR; Hesselink DA; van Gelder T; Sallustio BC
    Ther Drug Monit; 2011 Dec; 33(6):688-93. PubMed ID: 22105584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low and high density lipoproteins on renal cyclosporine A and cyclosporine G disposition in the isolated perfused rat kidney.
    Strong ML; Ueda CT
    Pharm Res; 1997 Oct; 14(10):1466-71. PubMed ID: 9358563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics.
    Song J; Kim MG; Choi B; Han NY; Yun HY; Yoon JH; Oh JM
    Ann Pharmacother; 2012 Sep; 46(9):1141-51. PubMed ID: 22947591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for clinical monitoring of cyclosporin in transplant patients.
    Dumont RJ; Ensom MH
    Clin Pharmacokinet; 2000 May; 38(5):427-47. PubMed ID: 10843461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A.
    Giese T; Zeier M; Schemmer P; Uhl W; Schoels M; Dengler T; Buechler M; Meuer S
    Transplantation; 2004 Feb; 77(3):339-44. PubMed ID: 14966405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I safety and pharmacokinetic studies of brequinar sodium after single ascending oral doses in stable renal, hepatic, and cardiac allograft recipients.
    Joshi AS; King SY; Zajac BA; Makowka L; Sher LS; Kahan BD; Menkis AH; Stiller CR; Schaefle B; Kornhauser DM
    J Clin Pharmacol; 1997 Dec; 37(12):1121-8. PubMed ID: 9506007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo distribution and erythrocyte binding characteristics of cyclosporin in renal transplant patients.
    Kurokawa N; Kadobayashi M; Yamamoto K; Arakawa Y; Sawada M; Takahara S; Okuyama A; Yanaihara C
    J Pharm Pharmacol; 1996 Jun; 48(6):553-9. PubMed ID: 8832486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine plasma unbound fraction in heart and lung transplantation recipients.
    Akhlaghi F; Ashley J; Keogh A; Brown K
    Ther Drug Monit; 1999 Feb; 21(1):8-16. PubMed ID: 10051049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of cyclosporin.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ
    Clin Pharmacokinet; 1986; 11(2):107-32. PubMed ID: 3514043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.